Inflammatory mediators and stroke: new opportunities for novel therapeutics - PubMed (original) (raw)
Review
Inflammatory mediators and stroke: new opportunities for novel therapeutics
F C Barone et al. J Cereb Blood Flow Metab. 1999 Aug.
Abstract
Contrary to previous dogmas, it is now well established that brain cells can produce cytokines and chemokines, and can express adhesion molecules that enable an in situ inflammatory reaction. The accumulation of neutrophils early after brain injury is believed to contribute to the degree of brain tissue loss. Support for this hypothesis has been drawn from many studies where neutrophil-depletion blockade of endothelial-leukocyte interactions has been achieved by various techniques. The inflammation reaction is an attractive pharmacologic opportunity, considering its rapid initiation and progression over many hours after stroke and its contribution to evolution of tissue injury. While the expression of inflammatory cytokines that may contribute to ischemic injury has been repeatedly demonstrated, cytokines may also provide "neuroprotection" in certain conditions by promoting growth, repair, and ultimately, enhanced functional recovery. Significant additional basic work is required to understand the dynamic, complex, and time-dependent destructive and protective processes associated with inflammation mediators produced after brain injury. The realization that brain ischemia and trauma elicit robust inflammation in the brain provides fertile ground for discovery of novel therapeutic agents for stroke and neurotrauma. Inhibition of the mitogen-activated protein kinase (MAPK) cascade via cytokine suppressive anti-inflammatory drugs, which block p38 MAPK and hence the production of interleukin-1 and tumor necrosis factor-alpha, are most promising new opportunities. However, spatial and temporal considerations need to be exercised to elucidate the best opportunities for selective inhibitors for specific inflammatory mediators.
Similar articles
- Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR, Anderson GD, Burnette BL, Compton RP, Devraj RV, Hirsch JL, Keith RH, Li X, Mbalaviele G, Messing DM, Saabye MJ, Schindler JF, Selness SR, Stillwell LI, Webb EG, Zhang J, Monahan JB. Hope HR, et al. J Pharmacol Exp Ther. 2009 Dec;331(3):882-95. doi: 10.1124/jpet.109.158329. Epub 2009 Aug 31. J Pharmacol Exp Ther. 2009. PMID: 19720877 Clinical Trial. - Modulation of endotoxin-induced endothelial function by calcium/calmodulin-dependent protein kinase.
Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Cuschieri J, et al. Shock. 2003 Aug;20(2):176-82. doi: 10.1097/01.shk.0000074789.29800.a5. Shock. 2003. PMID: 12865664 - Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha.
Feuerstein GZ, Liu T, Barone FC. Feuerstein GZ, et al. Cerebrovasc Brain Metab Rev. 1994 Winter;6(4):341-60. Cerebrovasc Brain Metab Rev. 1994. PMID: 7880718 Review. - Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets.
Feuerstein GZ, Wang X, Barone FC. Feuerstein GZ, et al. Ann N Y Acad Sci. 1997 Oct 15;825:179-93. doi: 10.1111/j.1749-6632.1997.tb48428.x. Ann N Y Acad Sci. 1997. PMID: 9369986 Review.
Cited by
- Evaluation of acetylcholinesterase and adenosine deaminase activities in brain and erythrocytes and proinflammatory cytokine levels in rats submitted to neonatal hypoxia-ischemia model.
Pimentel VC, Gomes JL, Zanini D, Abdalla FH, da Costa P, Gonçalves JF, Duarte MM, Moretto MB, Morsch VM, Schetinger MR. Pimentel VC, et al. Mol Cell Biochem. 2013 Jun;378(1-2):247-55. doi: 10.1007/s11010-013-1615-9. Epub 2013 Mar 21. Mol Cell Biochem. 2013. PMID: 23516038 - Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke.
Eckert A, Huang L, Gonzalez R, Kim HS, Hamblin MH, Lee JP. Eckert A, et al. Stem Cells Transl Med. 2015 Jul;4(7):841-51. doi: 10.5966/sctm.2014-0184. Epub 2015 May 29. Stem Cells Transl Med. 2015. PMID: 26025980 Free PMC article. - Topiramate suppresses peri-infarct spreading depolarization and improves outcomes in a rat model of photothrombotic stroke.
Wang Y, Yen S, Ian Shih YY, Lai CW, Chen YL, Chen LT, Chen H, Liao LD. Wang Y, et al. iScience. 2024 May 23;27(6):110033. doi: 10.1016/j.isci.2024.110033. eCollection 2024 Jun 21. iScience. 2024. PMID: 38947531 Free PMC article. - Magnesium sulfate and nimesulide have synergistic effects on rescuing brain damage after transient focal ischemia.
Wang LC, Huang CY, Wang HK, Wu MH, Tsai KJ. Wang LC, et al. J Neurotrauma. 2012 May 1;29(7):1518-29. doi: 10.1089/neu.2011.2030. Epub 2012 Mar 29. J Neurotrauma. 2012. PMID: 22332641 Free PMC article. - Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats.
Lively S, Schlichter LC. Lively S, et al. Transl Stroke Res. 2012 Jul;3(Suppl 1):132-46. doi: 10.1007/s12975-012-0151-3. Epub 2012 Mar 16. Transl Stroke Res. 2012. PMID: 22707991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources